Asymptomatic carotid lesion as a marker of future cerebrovascular and cardiovascular events.
Novo
S
S
Chair of Cardiovascular Diseases, Department of Clinical Medicine and Emerging Pathologies, University of Palermo. novosav@unipa.it
Corrado
E
E
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D002339:Carotid Arteries / Q000473:pathology*; D016893:Carotid Stenosis / Q000453:epidemiology* / Q000473:pathology / Q000601:surgery; D015897:Comorbidity; D016894:Endarterectomy, Carotid; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology*; D017539:Tunica Intima / Q000473:pathology
D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors